McIlrath & Eck’s CapForce IBD 50 ETF FFTY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$28.4K Hold
850
﹤0.01% 710
2025
Q4
$29.6K Hold
850
﹤0.01% 446
2025
Q3
$31.8K Hold
850
﹤0.01% 412
2025
Q2
$27.6K Hold
850
﹤0.01% 422
2025
Q1
$22.9K Hold
850
﹤0.01% 458
2024
Q4
$24.3K Hold
850
﹤0.01% 446
2024
Q3
$22.9K Hold
850
﹤0.01% 453
2024
Q2
$23.6K Sell
850
-625
-42% -$17K ﹤0.01% 424
2024
Q1
$40.8K Sell
1,475
-364
-20% -$9.52K 0.01% 313
2023
Q4
$44.8K Hold
1,839
0.01% 269
2023
Q3
$41.2K Hold
1,839
0.01% 288
2023
Q2
$47K Hold
1,839
0.01% 269
2023
Q1
$43.5K Hold
1,839
0.01% 276
2022
Q4
$40.1K Sell
1,839
-300
-14% -$7.4K 0.01% 282
2022
Q3
$52K Hold
2,139
0.01% 231
2022
Q2
$57K Hold
2,139
0.02% 216
2022
Q1
$84K Hold
2,139
0.02% 166
2021
Q4
$98K Hold
2,139
0.03% 149
2021
Q3
$101K Sell
2,139
-1,340
-39% -$62.6K 0.03% 127
2021
Q2
$161K Hold
3,479
0.05% 95
2021
Q1
$153K Hold
3,479
0.05% 86
2020
Q4
$143K Hold
3,479
0.05% 75
2020
Q3
$130K Hold
3,479
0.06% 68
2020
Q2
$120K Hold
3,479
0.06% 66
2020
Q1
$97K Hold
3,479
0.05% 70
2019
Q4
$121K Hold
3,479
0.06% 66
2019
Q3
$112K Sell
3,479
-35
-1% -$1.2K 0.06% 68
2019
Q2
$118K Hold
3,514
0.07% 59
2019
Q1
$118K Sell
3,514
-647
-16% -$20.4K 0.07% 59
2018
Q4
$115K Hold
4,161
0.07% 59
2018
Q3
$160K Sell
4,161
-1,535
-27% -$56.5K 0.09% 52
2018
Q2
$200K Sell
5,696
-3,838
-40% -$134K 0.12% 43
2018
Q1
$318K Buy
9,534
+6,883
+260% +$234K 0.19% 34
2017
Q4
$88K Buy
+2,651
New +$88K 0.05% 91

Other funds holding FFTY

McIlrath & Eck's FFTY Position: Q1 2026 in Review

McIlrath & Eck held its CapForce IBD 50 ETF (FFTY) position steady in Q1 2026 at 850 shares worth $28.4K. The position accounts for ﹤0.01% of the portfolio, ranked #710.

McIlrath & Eck first reported a position in FFTY in Q4 2017 and has held it in 34 quarters since. The position peaked at $318K in Q1 2018. 39 funds tracked by Wall St. Rank hold FFTY as of Q1 2026.

  • McIlrath & Eck held 850 shares of CapForce IBD 50 ETF worth $28.4K as of Q1 2026.
  • McIlrath & Eck left its CapForce IBD 50 ETF share count unchanged in Q1 2026.
  • CapForce IBD 50 ETF made up ﹤0.01% of McIlrath & Eck's portfolio in Q1 2026, its #710 holding.
  • McIlrath & Eck first reported a position in CapForce IBD 50 ETF in Q4 2017 and has held it in 34 quarters since.
  • McIlrath & Eck's CapForce IBD 50 ETF position peaked at $318K in Q1 2018.
  • 39 funds tracked by Wall St. Rank held CapForce IBD 50 ETF as of Q1 2026.

Based on McIlrath & Eck's 13F filing for Q1 2026, filed 19 May 2026.